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Serotype 6D of Streptococcus pneumoniae has been reported in Asia and the Fijian islands
among nasopharyngeal carriage isolates. We now report a 6D isolate from a Finnish adult with
invasive pneumococcal disease. Interestingly, the Finnish isolate and Asian isolate capsule gene
loci are almost identical.
INTRODUCTION
Recently, serotype 6D was predicted to be a new member of
serogroup 6 of Streptococcus pneumoniae (pneumococcus)
(Bratcher et al., 2009), but, until recently, extensive
searches by one of us (M.H.N) and investigators at the
Centers for Disease Control and Prevention in the USA
failed to show its presence in North America, South
America, Europe and Africa (Bratcher et al., 2009; Da
Gloria Carvalho et al., 2009; Hermans et al., 2008). Finally,
serotype 6D was found in Asia (Bratcher et al., 2010) and
the Fiji islands (Jin et al., 2009). However, since its presence
has not been detected in large parts of the world, the
clinical significance of serotype 6D has been unclear. We
now report an invasive European 6D isolate with a capsule
gene locus (cps) that is highly related to an Asian isolate.
METHODS
Quellung reaction. Pneumococci were serotyped using various
factor sera from Statens Serum Institute (SSI) as previously described
(Bratcher et al., 2009).
Flow cytometry. To investigate the epitopes being expressed,
pneumococci in suspension were stained first with one of several
hybridoma culture supernatants and then with fluorescein-conjugated
goat anti-mouse immunoglobulin antibody as previously described
(Bratcher et al., 2010).
PCR and DNA sequencing. Bacterial genomic DNA was extracted
and the cps region was PCR amplified with primers as described
previously (Bratcheretal.,2010). Theresulting ampliconwassequenced
at the Genomics Core at the University of Alabama at Birmingham
(Birmingham, AL, USA) as previously described (Bratcher et al., 2010).
RESULTS
A pneumococcal isolate (MNZ920) was obtained in 2009
from a blood culture of an elderly female in Finland. The
isolate was identified as pneumococcus (S. pneumoniae),
based on colony morphology, typical Gram stain appear-
ance, bile solubility and optochin sensitivity. It was initially
typed as 6B by counter-immunoelectrophoresis and the
quellung reaction, although serotype 6B is known to be
reactive with factor serum 6c, but not 6d (Table 1). Later,
along with a validation process for setting up new
serotyping methods, the isolate was found to be reactive
with new factor serum 6d and to harbour wciNb (Table 1),
a gene associated with serotypes 6C and 6D, by PCR and
sequencing (Bratcher et al., 2009). The isolate was then sent
to the SSI in Denmark and the University of Alabama at
Birmingham in the USA for additional studies.
In Denmark, serological investigation was performed with
the factor sera available at that time. The Danish study
confirmed that the isolate was positive with both factor
sera 6c and 6d but negative with factor serum 6b (Table 1).
This distinct serological pattern has recently been shown to
be indicative of serotype 6D, whereas serotype 6C is
negative to factor serum 6c but positive to factor serum 6d
(Table 1) (Bratcher & Nahm, 2010). In the USA, the isolate
was examined with mAb and flow cytometry, and was
found to be reactive with Hyp6BM8 but not with
Hyp6AG1, Hyp6AM3 and Hyp6BM7. This reaction pattern
was previously found to be the serological pattern
characteristic of serotype 6D (Bratcher et al., 2009, 2010).
Additional DNA sequencing studies showed that the isolate
Abbreviations: SSI, Statens Serum Institute; ST, sequence type.
The GenBank/EMBL/DDBJ accession number for the sequence of the
15.9 kb cps region of the MNZ920 isolate reported in this paper is
HM448897.
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no. HM448897) and a novel sequence type (ST), ST5163.
To investigate the evolutionary origin of the Finnish 6D
cps, the DNA sequence of the 15.9 kb in the cps region of
MNZ920 was determined as described previously (Park
et al., 2007) and deposited in GenBank (GenBank accession
no. HM448897). The 15.9 kb region includes all 14 genes
from cpsA to rmlD that are necessary for producing
serotype 6D polysaccharide. Comparison of the sequence
with the Korean 6D cps (GenBank accession no.
HM171374) showed the entire 15.9 kb sequence to be
highly homologous (99.2% identity) and the great
majority of the differences are found in rmlA, rmlB, rmlC
and rmlD genes. When the 5 kb central regions with low
G+C content (from the wciNb to the wzx region) were
compared, the homology between the Korean and Finnish
isolates was even greater (99.9% identity). It is interesting
to note that the 6D cps regions of these two isolates from
very distant parts of the world are almost identical, even
though the ST of the Korean 6D is quite different from the
ST of the Finnish 6D (ST282 vs ST5163). Further studies
with additional serotype 6D isolates are needed to
investigate how serotype 6D originated in different parts
of the world.
DISCUSSION
Until the Finnish isolate was found, all of the 6D isolates
described had been obtained from the nasopharynges of
healthy children (Bratcher et al., 2010; Jin et al., 2009).
However, the Finnish isolate was obtained from an elderly
adult suffering from invasive pneumococcal disease. Thus,
disease profiles of serotype 6D infections may be as
heterogeneous as those associated with other pneumococci
expressing different serotypes, although further studies are
required to confirm this.
As this case illustrates, serotype 6D may be confused with
either 6B or 6C. DNA testing may be difficult because the
genetic distinction between 6C and 6D may be just 1 bp in
the wciP gene (Mavroidi et al., 2004). However, currently
available factor sera can be used to easily distinguish 6D
from the other three members of serogroup 6, as shown in
Table 1. Since serotype 6D cps appears to have spread to
two distant locations (Korea and Finland) after its first
appearance, serotype 6D cps might also have spread to
many other locations in the world. We therefore believe
that serotype 6D will eventually be identified worldwide.
Awareness of the serological pattern of 6D and vigilance
during serotype screening should facilitate the recognition
of additional 6D isolates. In fact, since our manuscript was
submitted for review, a group have reported finding 6D
isolates in Poland, which were identified among invasive
pneumococcal disease isolates with PCR tests alone (Kuch
et al., 2010).
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